Atypical parkinsonism

From Wikiversity
Jump to: navigation, search

< Back to: Progress and Prospects in Parkinson's Research

A range of overlapping neurological conditions with similar symptoms gives rise to frequent diagnostic problems.

Background[edit]

The following table identifies some common neurological disorders, their 'trademark' pathological characteristics, and the parts of the CNS affected

Condition Pathology Neurology
Alzheimer's disease Amyloid plaques, Neurofibrillary tangles Cerebral cortex, Hippocampus,Basal nucleus of Meynert
Corticobasal degeneration Ballooned neurons with tau inclusions Cerebral cortex,Basal ganglia
Lewy body dementia Lewy bodies Cerebral cortex, Basal ganglia, Basal nucleus of Meynert
Multiple system atrophy Alpha-synuclein inclusions Hindbrain structures involved in balance and autonomic functions
Parkinson's disease Lewy bodies Substantia nigra, Dorsal nucleus of vagus,Basal nucleus of Meynert
Progressive supranuclear palsy Neurofibrillary tangles Cerebral cortex, Basal ganglia, Spinal cord, Midbrain
Vascular dementia Vascular infarctions, Cerebral cortex, Hippocampus

Research[edit]

1992

Hughes et al [1] re-evaluated 100 patients diagnosed prospectively by a group of consultant neurologists as having idiopathic Parkinson's disease .

In 24 cases without Lewy bodies, diagnoses included progressive supranuclear palsy, multiple system atrophy, Alzheimer's disease, Alzheimer-type pathology, and basal ganglia vascular disease. The retrospective application of recommended diagnostic criteria improved the diagnostic accuracy to 82%. These observations call into question current concepts of Parkinson's disease as a single distinct morbid entity.


2003


Yekhief et al [2] evaluated the use of MRI scans in the diagnosis of PD and PD+ syndromes.

The “cortical” score distinguished CBD and PSP from MSA with a fair PPV (>90%). The PPV of the “putaminal” score was high (70%) for the differential diagnosis of MSA with PSP and CBD. The “midbrain” score was significantly higher in PSP and CBD compared to MSA. These results are in accordance with the underlying pathology found in these disorders and demonstrate that a simple MRI scoring procedure may help the neurologist to differentiate primary causes of parkinsonism in everyday practice.

Further Reading[edit]

Related pages[edit]

< Back to parent page: Progress and Prospects in Parkinson's Research

Subpages:

MSA, PSP, DLB

References[edit]

<references>

  1. Hughes, A.J.; Daniel, S.E.: Kilford, L. and Lees, A.J. (1992) Abstract J Neurol Neurosurg Psychiatry 55: (3) 181-184 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. http://jnnp.bmj.com/content/55/3/181.short
  2. Yekhief, F.; Ballan, G.: Macia, F.; Delmer, O.; Sourgen, C. and Tison, F. Ful Te(2003)Full Text J. of Neur. Transm.110(2) 151-169 Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD http://www.springerlink.com/content/rk1v1eeq1a23ry08/